Abstract

The aim of this study is to evaluate effective dose received by participants from Lung Cancer Screening program in Institut Kanser Negara (IKN), Putrajaya. This retrospective study was performed between April 2016 - December 2016 where all scanning acquisition protocols and dose information from forty (40) participants were recorded and investigated. The screening process involves two types of imaging technique, the Dual Energy Subtraction (DES) Chest Xray and Low-Dose Computed Tomography (LDCT) imaging technique. Participant’s effective dose (ED) from DES and MSCT were analysed by using PCXMC (Version 2.0, Finland) and CT-EXPO (Version 2.3, Germany) software, respectively. It was observed that the mean ( ± SD) value for DES (at 60 kV), DES (at 120 kV) and MSCT examinations were 0.006 ± 0.005 mSv, 0.018 ± 0.005 mSv and 1.558 ± 0.129 mSv, respectively. In a whole, the total cumulative ED values for participants were ranged from 1.376 mSv to 1.986 mSv. It was summarized that both optimized techniques were useful for screening needs and the ED value from this study were lower when compared to other established reference.

Highlights

  • The aim of this study is to evaluate effective dose received by participants from Lung Cancer Screening program in Institut Kanser Negara (IKN), Putrajaya

  • This retrospective study was performed between April 2016 – December 2016 where all scanning acquisition protocols and dose information from forty (40) participants were recorded and investigated

  • Participant’s effective dose (ED) from Dual Energy Subtraction (DES) and MSCT were analysed by using PCXMC (Version 2.0, Finland) and CT-EXPO (Version 2.3, Germany) software, respectively

Read more

Summary

Introduction

The aim of this study is to evaluate effective dose received by participants from Lung Cancer Screening program in Institut Kanser Negara (IKN), Putrajaya.

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.